<--- Back to Details
First PageDocument Content
Abortifacients / Food and Drug Administration / Pharmacology / Gynaecology / Fertility / Mifepristone / Misoprostol / New Drug Application / Medical abortion / Medicine / Health / Human reproduction
Date: 2003-10-24 17:59:43
Abortifacients
Food and Drug Administration
Pharmacology
Gynaecology
Fertility
Mifepristone
Misoprostol
New Drug Application
Medical abortion
Medicine
Health
Human reproduction

Kirkpatrick & Lockhart October lo,2003

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 3,46 MB

Share Document on Facebook

Similar Documents

Baseline Curriculum for Reproductive Health MSFC believes that abortion and family planning training should be a standard part of all medical school curricula. Formally improving your school’s reproductive health curri

DocID: 1uSKE - View Document

Briefing on the proposal to regulate termination of pregnancy in early pregnancy (12 weeks): Medical Abortion Briefing on the proposal to regulate termination of pregnancy in

DocID: 1tOIN - View Document

Protect Safe and Legal Abortion Studies Show Abortion Has 99 Percent Safety Record; One of Safest Medical Procedures Performed in U.S. In 1973, the U.S. Supreme Court ruled in Roe v. Wade that a woman’s constitutional

DocID: 1tMv0 - View Document

MEDICAL AND SOCIAL HEALTH BENEFITS SINCE ABORTION WAS MADE LEGAL IN THE U.S Despite the claims of those who oppose safe and legal abortion, many demonstrable health benefits — physical, emotional, and social — have a

DocID: 1tCDn - View Document

Inquiry into Abortion on the Grounds of Disability Submission from the Christian Medical Fellowship Name: Philippa Taylor Contact details: Name of Organisation: Christian Medical Fellowship

DocID: 1sTAX - View Document